KIMBERLY NOVENSKI: Open Payments
NPI 1831817477 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,623 in 125 payments from 18 companies in 2025. Trend: 2023 $3,842 · 2024 $2,682 · 2025 $3,623
Food & beverage: $3,623
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 24 | $799 |
| E.R. Squibb & Sons, L.L.C. | 18 | $476 |
| AstraZeneca Pharmaceuticals LP | 6 | $441 |
| Novartis Pharmaceuticals Corporation | 15 | $255 |
| Edwards Lifesciences Corporation | 2 | $224 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $212 |
| Novo Nordisk Inc | 5 | $208 |
| Esperion Therapeutics, Inc. | 14 | $169 |
| Boston Scientific Corporation | 2 | $155 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 8 | $150 |
Products named: REPATHA, CAMZYOS, LOKELMA, LEQVIO, SAPIEN 3 Ultra RESILIA, JARDIANCE, NEXLETOL, WATCHMAN FLX.
Industry payments across AZ — which companies pay providers there.
